What's breaking now, across thousands of outlets.
The deal gives BioMarin access to ALE1, a small-molecule drug in early-stage trials that could become the first oral therapy for hypophosphatasia
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
Former Hartbeat president Bryan Smiley explains why brands are overlooking Gen Z men and how Hard Carry Media is building the next generation of creator-driven entertainment.
Roland Busch replies to emails with ‘OK’ or ‘No’ and refuses to hold recurring one-on-ones. He’s not the only CEO cutting the fat.
Roland Busch replies to emails with “OK” or “No” and refuses to hold recurring one-on-ones. He’s not the only CEO cutting the fat.
John Loos, independent economist, discuss the impending PIC transaction, building cycle since COVID-19 pandemic and Balwin’s tenure at the JSE as it prepares to delist.
Seel, an AI-driven operations platform for commerce, today launched a new resale capability within its order center that allows shoppers to recover value from their gently used clothes when they’re no…
Robust compensation and metering, along with strong customer protections, are needed to drive participation in utility virtual power plants programs, according to experts.
